Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Acta Neuropathol

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    March 2017
  1. RAPP C, Warta R, Stamova S, Nowrouzi A, et al
    Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens.
    Acta Neuropathol. 2017 Mar 22. doi: 10.1007/s00401-017-1702.
    PubMed     Text format     Abstract available


  2. PEKMEZCI M, Rice T, Molinaro AM, Walsh KM, et al
    Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
    Acta Neuropathol. 2017 Mar 2. doi: 10.1007/s00401-017-1690.
    PubMed     Text format     Abstract available


    January 2017
  3. OLAR A, Wani KM, Wilson CD, Zadeh G, et al
    Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
    Acta Neuropathol. 2017 Jan 27. doi: 10.1007/s00401-017-1678.
    PubMed     Text format     Abstract available


  4. LENTING K, Verhaak R, Ter Laan M, Wesseling P, et al
    Glioma: experimental models and reality.
    Acta Neuropathol. 2017 Jan 10. doi: 10.1007/s00401-017-1671.
    PubMed     Text format     Abstract available


    December 2016
  5. EL-HABR EA, Dubois LG, Burel-Vandenbos F, Bogeas A, et al
    A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.
    Acta Neuropathol. 2016 Dec 28. doi: 10.1007/s00401-016-1659.
    PubMed     Text format     Abstract available


    August 2016
  6. TABOURET E, Nguyen AT, Dehais C, Carpentier C, et al
    Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
    Acta Neuropathol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  7. BAUMGARTEN P, Gessler F, Schittenhelm J, Skardelly M, et al
    Brain invasion in otherwise benign meningiomas does not predict tumor recurrence.
    Acta Neuropathol. 2016.
    PubMed     Text format    


    May 2016
  8. FERRIS SP, Goode B, Joseph NM, Kline CN, et al
    IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
    Acta Neuropathol. 2016.
    PubMed     Text format    


  9. CASTEL D, Grill J, Debily MA
    Histone H3 genotyping refines clinico-radiological diagnostic and prognostic criteria in DIPG.
    Acta Neuropathol. 2016;131:795-6.
    PubMed     Text format    


    April 2016
  10. RAMASWAMY V, Remke M, Bouffet E, Bailey S, et al
    Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Acta Neuropathol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  11. JANSEN MH, Veldhuijzen van Zanten SE, Heymans MW, Hargrave D, et al
    Commentary on "Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes".
    Acta Neuropathol. 2016.
    PubMed     Text format    


    January 2016
  12. BRONISCER A, Chamdine O, Hwang S, Lin T, et al
    Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
    Acta Neuropathol. 2016.
    PubMed     Text format     Abstract available


  13. HERRLINGER U, Jones DT, Glas M, Hattingen E, et al
    Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Acta Neuropathol. 2016.
    PubMed     Text format    


    December 2015
  14. BRANDENBURG S, Muller A, Turkowski K, Radev YT, et al
    Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  15. SAHM F, Schrimpf D, Jones DT, Meyer J, et al
    Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  16. HERRLINGER U, Jones DT, Glas M, Hattingen E, et al
    Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  17. CASTEL D, Philippe C, Calmon R, Le Dret L, et al
    Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  18. LIU Q, Liu Y, Li W, Wang X, et al
    Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  19. HO CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, et al
    A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  20. GESSI M, Gielen GH, Dreschmann V, Waha A, et al
    High frequency of H3F3A mutations characterizes pediatric and adult high-grade gliomas of the spinal cord.
    Acta Neuropathol. 2015.
    PubMed     Text format    


    July 2015
  21. MENKE JR, Raleigh DR, Gown AM, Thomas S, et al
    Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.
    Acta Neuropathol. 2015.
    PubMed     Text format    


    June 2015
  22. LIVERMAN C, Mafra M, Chuang SS, Shivane A, et al
    A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern.
    Acta Neuropathol. 2015.
    PubMed     Text format    


  23. OHLI J, Neumann JE, Grammel D, Schuller U, et al
    Localization of SHH medulloblastoma in mice depends on the age at its initiation.
    Acta Neuropathol. 2015.
    PubMed     Text format    


  24. ICHIMURA K, Narita Y, Hawkins CE
    Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015;129:789-808.
    PubMed     Text format     Abstract available


  25. REUSS DE, Mamatjan Y, Schrimpf D, Capper D, et al
    IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
    Acta Neuropathol. 2015;129:867-73.
    PubMed     Text format     Abstract available


  26. WESSELING P, van den Bent M, Perry A
    Oligodendroglioma: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015;129:809-27.
    PubMed     Text format     Abstract available


  27. THOMAS C, Ruland V, Kordes U, Hartung S, et al
    Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older children.
    Acta Neuropathol. 2015;129:925-7.
    PubMed     Text format    


  28. DE LA FOUCHARDIERE A, Cabaret O, Petre J, Aydin S, et al
    Primary leptomeningeal melanoma is part of the BAP1-related cancer syndrome.
    Acta Neuropathol. 2015;129:921-3.
    PubMed     Text format    


  29. COLLINS VP, Jones DT, Giannini C
    Pilocytic astrocytoma: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015;129:775-88.
    PubMed     Text format     Abstract available


    May 2015
  30. PAULUS W
    Pathology, molecular mechanisms and markers of gliomas: new insight and new challenges.
    Acta Neuropathol. 2015.
    PubMed     Text format    


  31. ALDAPE K, Zadeh G, Mansouri S, Reifenberger G, et al
    Glioblastoma: pathology, molecular mechanisms and markers.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  32. GEISENBERGER C, Mock A, Warta R, Rapp C, et al
    Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  33. NAVIS AC, van Lith SA, van Duijnhoven SM, de Pooter M, et al
    Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  34. RODRIGUEZ FJ, Schniederjan MJ, Nicolaides T, Tihan T, et al
    High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN).
    Acta Neuropathol. 2015;129:609-10.
    PubMed     Text format    


    March 2015
  35. WELLER M, Weber RG, Willscher E, Riehmer V, et al
    Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  36. KORSHUNOV A, Ryzhova M, Hovestadt V, Bender S, et al
    Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  37. WANG X, Dubuc AM, Ramaswamy V, Mack S, et al
    Medulloblastoma subgroups remain stable across primary and metastatic compartments.
    Acta Neuropathol. 2015;129:449-57.
    PubMed     Text format     Abstract available


    February 2015
  38. VAN THUIJL HF, Mazor T, Johnson BE, Fouse SD, et al
    Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  39. BEST MG, Sol N, Zijl S, Reijneveld JC, et al
    Liquid biopsies in patients with diffuse glioma.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  40. OLAR A, Wani KM, Alfaro-Munoz KD, Heathcock LE, et al
    IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
    Acta Neuropathol. 2015.
    PubMed     Text format     Abstract available


  41. POSCHL J, Koch A, Schuller U
    Histological subtype of medulloblastoma frequently changes upon recurrence.
    Acta Neuropathol. 2015.
    PubMed     Text format    


    January 2015
  42. SAHM F, von Deimling A
    Farewell to oligoastrocytoma: response to letters.
    Acta Neuropathol. 2015;129:155.
    PubMed     Text format    


  43. WILCOX P, Li CC, Lee M, Shivalingam B, et al
    Oligoastrocytomas: throwing the baby out with the bathwater?
    Acta Neuropathol. 2015;129:147-9.
    PubMed     Text format    


    November 2014
  44. REUSS DE, Sahm F, Schrimpf D, Wiestler B, et al
    ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Acta Neuropathol. 2014.
    PubMed     Text format     Abstract available


    October 2014
  45. HUSE JT, Diamond EL, Wang L, Rosenblum MK, et al
    Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true "oligoastrocytoma"?
    Acta Neuropathol. 2014.
    PubMed     Text format    


  46. SAHM F, Reuss D, Koelsche C, Capper D, et al
    Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Acta Neuropathol. 2014;128:551-9.
    PubMed     Text format     Abstract available


  47. DE KOCK L, Sabbaghian N, Druker H, Weber E, et al
    Germ-line and somatic DICER1 mutations in pineoblastoma.
    Acta Neuropathol. 2014;128:583-95.
    PubMed     Text format     Abstract available


    August 2014
  48. WESSELING P
    Embryonal tumor with multilayered rosettes (ETMR): signed, sealed, delivered ....
    Acta Neuropathol. 2014;128:305-8.
    PubMed     Text format    


  49. BIELLE F, Zanello M, Guillemot D, Gil-Delgado M, et al
    Unusual primary cerebral localization of a CIC-DUX4 translocation tumor of the Ewing sarcoma family.
    Acta Neuropathol. 2014;128:309-11.
    PubMed     Text format    


  50. SPENCE T, Sin-Chan P, Picard D, Barszczyk M, et al
    CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
    Acta Neuropathol. 2014;128:291-303.
    PubMed     Text format     Abstract available


  51. KORSHUNOV A, Sturm D, Ryzhova M, Hovestadt V, et al
    Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
    Acta Neuropathol. 2014;128:279-89.
    PubMed     Text format     Abstract available


    July 2014
  52. BLUMCKE I, Russo GL, Najm I, Palmini A, et al
    Pathology-based approach to epilepsy surgery.
    Acta Neuropathol. 2014;128:1-3.
    PubMed     Text format    


  53. DE KOCK L, Sabbaghian N, Plourde F, Srivastava A, et al
    Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
    Acta Neuropathol. 2014;128:111-22.
    PubMed     Text format     Abstract available


    May 2014
  54. HOFFMAN LM, Donson AM, Nakachi I, Griesinger AM, et al
    Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma.
    Acta Neuropathol. 2014;127:731-45.
    PubMed     Text format     Abstract available


    April 2014
  55. PIETSCH T, Wohlers I, Goschzik T, Dreschmann V, et al
    Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-kappaB signaling pathway.
    Acta Neuropathol. 2014;127:609-11.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: